These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 38065764)

  • 1. A realist evaluation of the development of extended pharmacist roles and services in community pharmacies.
    Morris C; McDonald J; Officer TN; Fa'asalele Tanuvasa A; Smiler K; Parore N; Dunn P; McKinlay E; Kennedy J; McBride-Henry K; Cumming J
    Res Social Adm Pharm; 2024 Mar; 20(3):321-334. PubMed ID: 38065764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A national survey of pharmacists and interns in Aotearoa New Zealand: provision and views of extended services in community pharmacies.
    McDonald J; Morris C; Pledger M; Dunn P; Fa'asalele Tanuvasa A; Smiler K; Cumming J
    BMC Health Serv Res; 2021 Oct; 21(1):1147. PubMed ID: 34688303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of community pharmacy-based services for type-2 diabetes in an Indonesian setting: pharmacist survey.
    Wibowo Y; Parsons R; Sunderland B; Hughes J
    Int J Clin Pharm; 2015 Oct; 37(5):873-82. PubMed ID: 25986291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid realist review of the role of community pharmacy in the public health response to COVID-19.
    Maidment I; Young E; MacPhee M; Booth A; Zaman H; Breen J; Hilton A; Kelly T; Wong G
    BMJ Open; 2021 Jun; 11(6):e050043. PubMed ID: 34135054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A national survey exploring oral healthcare service provision across Australian community pharmacies.
    Freeman CR; Abdullah N; Ford PJ; Taing MW
    BMJ Open; 2017 Sep; 7(9):e017940. PubMed ID: 28963314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implementation of a mental health medication management intervention in Australian community pharmacies: Facilitators and challenges.
    Hattingh HL; Kelly F; Fowler J; Wheeler AJ
    Res Social Adm Pharm; 2017; 13(5):969-979. PubMed ID: 28583302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What works for whom in pharmacist-led smoking cessation support: realist review.
    Greenhalgh T; Macfarlane F; Steed L; Walton R
    BMC Med; 2016 Dec; 14(1):209. PubMed ID: 27978837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful implementation and provision of enhanced and extended pharmacy services.
    Hattingh L; Sim TF; Sunderland B; Czarniak P
    Res Social Adm Pharm; 2020 Apr; 16(4):464-474. PubMed ID: 31272922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expanded practice in rural community pharmacy: a macro-, meso and micro-level perspective.
    Taylor S; Cairns A; Glass B
    Rural Remote Health; 2021 Jul; 21(3):6158. PubMed ID: 34304577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring the factors influencing the quality of "Health Support Pharmacy" services in Japan: Perspectives of community pharmacists.
    Sato N; Fujita K; Kushida K; Chen TF
    Res Social Adm Pharm; 2020 Dec; 16(12):1686-1693. PubMed ID: 32147461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of pharmacy and pharmacist characteristics on the secondary prevention of cardiovascular disease.
    Puspitasari HP; Aslani P; Krass I
    Int J Clin Pharm; 2015 Oct; 37(5):834-43. PubMed ID: 25964140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Examination of England's New Medicine Service (NMS) of complex health care interventions in community pharmacy.
    Latif A; Waring J; Watmough D; Barber N; Chuter A; Davies J; Salema NE; Boyd MJ; Elliott RA
    Res Social Adm Pharm; 2016; 12(6):966-989. PubMed ID: 26806858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Community pharmacy-based injectable naltrexone service delivery models and best practices.
    Ford JH; Gilson AM; Bryan G; Augustine C; Gassman M; Mott DA
    Res Social Adm Pharm; 2021 Jul; 17(7):1332-1341. PubMed ID: 33268242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A qualitative case study exploring the implementation of pharmacist care planning services in community pharmacies.
    Hughes CA; Breault RR; Schindel TJ
    J Am Pharm Assoc (2003); 2020; 60(4):580-588.e2. PubMed ID: 31953119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Community pharmacists' perceptions of services that benefit older people in New Zealand.
    Tordoff J; Chang SY; Norris PT
    Int J Clin Pharm; 2012 Apr; 34(2):342-50. PubMed ID: 22328011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants of community pharmacists' quality of care: a population-based cohort study using pharmacy administrative claims data.
    Winslade N; Tamblyn R
    BMJ Open; 2017 Sep; 7(9):e015877. PubMed ID: 28939571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacists views on participating in New Zealand's community pharmacy anticoagulation management service: a mixed-methods study.
    Beyene K; Chan AHY; Barton E; Yan S; Singh S; Basani A; Voong J; Harrison J
    Int J Clin Pharm; 2021 Feb; 43(1):251-262. PubMed ID: 32920685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A cross-sectional survey of enhanced and extended professional services in community pharmacies: A pharmacy perspective.
    Sim TF; Wright B; Hattingh L; Parsons R; Sunderland B; Czarniak P
    Res Social Adm Pharm; 2020 Apr; 16(4):511-521. PubMed ID: 31300355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacist health coaching in Australian community pharmacies: What do pharmacy professionals think?
    Singh HK; Kennedy GA; Stupans I
    Health Soc Care Community; 2020 Jul; 28(4):1190-1198. PubMed ID: 32020737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacist views and pharmacy capacity to deliver professional services in the United Arab Emirates.
    Alzubaidi H; Saidawi W; Mc Namara K
    Int J Clin Pharm; 2018 Oct; 40(5):1106-1115. PubMed ID: 29926256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.